Baillie Gifford & CO Burning Rock Biotech LTD Transaction History

Baillie Gifford & CO

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 13, 2023	SELL	$0.91 - $2.29 $2,974 - $7,486	-3,269 Reduced 2.04%	156,912 $152,000
Q3 2022 Oct 27, 2022	SELL	$2.39 - $3.96 $424,731 - $703,739	-177,712 Reduced 52.59%	160,181 $383,000
Q2 2022 Aug 08, 2022	SELL	$1.75 - $10.44 $15 Million - $89.5 Million	-8,573,357 Reduced 96.21%	337,893 $983,000
Q1 2022 May 05, 2022	BUY	$6.7 - $10.23 $72,004 - $109,941	10,747 Added 0.12%	8,911,250 $82.8 Million
Q4 2021 Jan 20, 2022	BUY	$9.43 - $17.14 $1.02 Million - $1.86 Million	108,351 Added 1.23%	8,900,503 $84.8 Million
Q3 2021 Oct 19, 2021	BUY	$17.37 - $27.92 $5.73 Million - $9.21 Million	329,730 Added 3.9%	8,792,152 $157 Million
Q2 2021 Aug 02, 2021	BUY	$26.14 - $37.45 $49.2 Million - $70.4 Million	1,880,294 Added 28.57%	8,462,422 $249 Million
Q1 2021 May 06, 2021	BUY	$23.5 - $39.58 $118 Million - $198 Million	5,004,571 Added 317.24%	6,582,128 $177 Million
Q4 2020 Feb 10, 2021	BUY	$22.55 - $30.87 $12.7 Million - $17.5 Million	565,285 Added 55.84%	1,577,557 $36.4 Million
Q3 2020 Nov 12, 2020	BUY	$19.07 - $29.61 $5.6 Million - $8.7 Million	293,672 Added 40.87%	1,012,272 $25.4 Million
Q2 2020 Aug 12, 2020	BUY	$23.21 - $31.43 $16.7 Million - $22.6 Million	718,600 New	718,600 $19.4 Million

21.2K

Ticker BNR
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 105,188,000
Market Cap $721M
Description
Burning Rock Biotech Limited primarily develops and provides cancer therapy selection tests in the People's Republic of China. It operates in three segments: Central Laboratory Business, In-Hospital Business, and Pharma Research and Development Services. The company primarily offers next-generation sequencing-based cancer therapy selection and p...

Get notified when there are updates to the investment portfolio of Baillie Gifford & CO, based on Form 13F filings with the SEC.

Stay updated on Baillie Gifford & CO with notifications on news.